Moleculin Biotech Stock (NASDAQ: MBRX) stock price, news, charts, stock research, profile.
Open | $3.46 |
Close | $3.52 |
Volume / Avg. | 9.49K / 21.54K |
Day Range | 3.36 - 3.61 |
52 Wk Range | 3.22 - 15.75 |
Market Cap | $7.97M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 0.96% |
Days to Cover | 1.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.
Other companies in Moleculin Biotech’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Coeptis Therapeutics (NASDAQ:COEP), NuCana (NASDAQ:NCNA) and ABVC BioPharma (NASDAQ:ABVC).
There is no analysis for Moleculin Biotech.
Moleculin Biotech has a consensus price target of $17.00.
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $3.45 last updated July 26, 2024 at 8:39 AM EDT.
There are no upcoming dividends for Moleculin Biotech.
Moleculin Biotech’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Moleculin Biotech.
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.